Investing.com - Lumos Pharma Inc (NASDAQ: LUMO) reported third quarter EPS of $-1.04, $0.11 better than the analyst estimate of $-1.15. Revenue for the quarter came in at $7K versus the consensus estimate of $225.4K.
Lumos Pharma Inc's stock price closed at $3.64. It is up 24.66% in the last 3 months and down -59.56% in the last 12 months.
Lumos Pharma Inc saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Lumos Pharma Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Lumos Pharma Inc's Financial Health score is "fair performance".
Check out Lumos Pharma Inc's recent earnings performance, and Lumos Pharma Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar